Albutrepenonacog alfa

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameAlbutrepenonacog alfa
Drug Alias Name阿凝血素-9αrFIX-FP阿布诺凝血素αAlbutrepenonacogum alfa重组人凝血因子IX-白蛋白融合蛋白 +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsHemophilia B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2016/03/04
Country/TerritoryCzechiaBulgariaCanada +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl BehringCsl Behring GmbhCsl Behring Llc
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeB02BD04
Related LinksKEGG